Generic placeholder image

Current HIV Research

Author(s): Bipasha Choudhury, Maria Stadnyk, Dolores Freire Jijon, Luke McLaughlin, Jamil N. Kanji, Carmen Charlton, Petra Smyczek, Wendy Vaudry, Stan Houston, Alena Tse-Chang and Michael T. Hawkes*

DOI: 10.2174/1570162X18999201231211658

DownloadDownload PDF Flyer Cite As
Pregnancy Among HIV-Serodiscordant Couples: Case Report of Vertical Transmission and Retrospective Case Series

Page: [269 - 276] Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Background: HIV transmission during pregnancy and breastfeeding among serodiscordant heterosexual couples represents an ongoing barrier to the elimination of vertical transmission of HIV-1 infection in Canada.

Objective: To report a case of vertical HIV transmission during breastfeeding and examine the prevalence of risk factors for HIV transmission in the pregnancy and postpartum periods among serodiscordant couples where the male partner is HIV positive and female partner HIV negative.

Methods: Case report and retrospective chart review of HIV-serodiscordant pregnant couples over an eight-year period in Edmonton, Canada.

Results: We report a case of maternal primary HIV infection during the postpartum period and vertical transmission to a nursing infant that went undetected until the infant presented with AIDS. We also report a series of 41 serodiscordant pregnant couples identified by our public health nurse between 2008 and 2016. Among HIV-infected male partners, 20 (49%) had a detectable viral load (VL) during their partner’s pregnancy and during breastfeeding, with median peak VL 4,700 copies/mL (range 49-120,000) and 5,100 copies/mL (range 40-120,000) during pregnancy and breastfeeding, respectively. None of the female partners seroconverted during pregnancy, but three seroconverted at 1.8, 2.4, and 6.9 years after delivery. No vertical transmission occurred.

Conclusion: Despite concerted attempts to minimize HIV transmission during pregnancy and breastfeeding in our well-resourced setting, residual transmission risk remains due to non-suppressed viral load within many HIV-serodiscordant pregnant couples.

Keywords: HIV, heterosexual transmission, vertical transmission, serodiscordant couple, prevention, pregnancy.

Graphical Abstract

[1]
Haddad N, Li JS, Totten S, McGuire M. HIV in Canada-Surveillance Report, 2017. Can Commun Dis Rep 2018; 44(12): 348-56.
[2]
Webber G. Mother-to-child transmission of HIV in Canada: a population health risk management perspective. J Obstet Gynaecol Can 2003; 25(9): 751-9.
[http://dx.doi.org/10.1016/S1701-2163(16)31004-0] [PMID: 12970810]
[3]
Fettig J, Swaminathan M, Murrill CS, Kaplan JE. Global epidemiology of HIV. Infect Dis Clin North Am 2014; 28(3): 323-37.
[http://dx.doi.org/10.1016/j.idc.2014.05.001] [PMID: 25151559]
[4]
Forbes JC, Alimenti AM, Singer J, et al. Canadian Pediatric AIDS Research Group (CPARG). A national review of vertical HIV transmission. AIDS 2012; 26(6): 757-63.
[http://dx.doi.org/10.1097/QAD.0b013e328350995c] [PMID: 22210635]
[5]
Bitnun A, Lee T, Brophy J, et al. Canadian Perinatal HIV Surveillance Program. Missed opportunities for prevention of vertical HIV transmission in Canada, 1997-2016: a surveillance study. CMAJ Open 2018; 6(2): E202-10.
[http://dx.doi.org/10.9778/cmajo.20180016] [PMID: 29759976]
[6]
Haddad N, Robert A, Weeks A, Popovic N, Siu W, Archibald C. HIV in Canada-Surveillance Report, 2018. Can Commun Dis Rep 2019; 45(12): 304-12.
[7]
Plitt SS, Smith TR, Berry W, Osman M, Senthilselvan A, Charlton CL. Examination of a Canadian provincial prenatal HIV screening program: 2010 to 2014. Can J Public Health 2020; 111(4): 555-61.
[http://dx.doi.org/10.17269/s41997-019-00281-6] [PMID: 32016920]
[8]
Johnson LF, Stinson K, Newell ML, Bland RM, Moultrie H, Davies MA, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. Journal of acquired immune deficiency syndromes 2012; 59(4): 417-25.
[http://dx.doi.org/10.1097/QAI.0b013e3182432f27]
[9]
Zorrilla CD, Báez FR, Colón KG, Ibarra J, García I, Mosquera AM. HIV seroconversion during pregnancy and the need for pre- exposure prophylaxis (PrEP). HIV AIDS (Auckl) 2018; 10: 57-61.
[http://dx.doi.org/10.2147/HIV.S140799] [PMID: 30804684]
[10]
Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004; 292(2): 202-9.
[http://dx.doi.org/10.1001/jama.292.2.202] [PMID: 15249569]
[11]
Barin F, Jourdain G, Brunet S, et al. Perinatal HIV Prevention Trial Group. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis 2006; 193(11): 1504-11.
[http://dx.doi.org/10.1086/503778] [PMID: 16652277]
[12]
Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM. Cell-free virus in breast milk of HIV-1-seropositive women. Journal of acquired immune deficiency syndromes 1999; 24(4): 330-6.
[13]
Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother- to-child transmission. J Infect Dis 2004; 190(10): 1880-8.
[http://dx.doi.org/10.1086/425076] [PMID: 15499546]
[14]
Eisinger RW, Dieffenbach CW, Fauci AS. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA 2019; 321(5): 451-2.
[http://dx.doi.org/10.1001/jama.2018.21167] [PMID: 30629090]
[15]
LeMessurier J, Traversy G, Varsaneux O, et al. Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review. CMAJ 2018; 190(46): E1350-60.
[http://dx.doi.org/10.1503/cmaj.180311] [PMID: 30455270]
[16]
R. R Core Team. R: A language and environment for statistical computing R version 362 (2019-12-12) R Foundation for Statistical Computing, Vienna, Austria 2019.https://www.R-project.org/
[17]
Thomson KA, Hughes J, Baeten JM, et al. Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams. Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per- Coital-Act Analysis Among Women With HIV-Infected Partners. J Infect Dis 2018; 218(1): 16-25.
[http://dx.doi.org/10.1093/infdis/jiy113] [PMID: 29514254]
[18]
Blumental S, Ferster A, Van den Wijngaert S, Lepage P. HIV transmission through breastfeeding: still possible in developed countries. Pediatrics 2014; 134(3): e875-9.
[http://dx.doi.org/10.1542/peds.2013-3022] [PMID: 25136040]
[19]
Judd A, Chappell E, Turkova A, et al. European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study. PLoS Med 2018; 15(1): e1002491.
[http://dx.doi.org/10.1371/journal.pmed.1002491] [PMID: 29381702]
[20]
Ziegler JB, Cooper DA, Johnson RO, Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; 1(8434): 896-8.
[http://dx.doi.org/10.1016/S0140-6736(85)91673-3] [PMID: 2858746]
[21]
Bulterys M, Chao A, Dushimimana A, et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS 1993; 7(12): 1639-45.
[http://dx.doi.org/10.1097/00002030-199312000-00015] [PMID: 8286074]
[22]
Burgess T. Determinants of transmission of HIV from mother to child. Clin Obstet Gynecol 2001; 44(2): 198-209.
[http://dx.doi.org/10.1097/00003081-200106000-00009] [PMID: 11344988]
[23]
Hira SK, Mangrola UG, Mwale C, et al. Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 1990; 117(3): 421-4.
[http://dx.doi.org/10.1016/S0022-3476(05)81084-4] [PMID: 2391598]
[24]
Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340(8819): 585-8.
[http://dx.doi.org/10.1016/0140-6736(92)92115-V] [PMID: 1355163]
[25]
Manigart O, Crepin M, Leroy V, et al. Diminution de la Transmission Mere-Enfant Study Group. Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission. J Infect Dis 2004; 190(8): 1422-8.
[http://dx.doi.org/10.1086/424569] [PMID: 15378434]
[26]
Palasanthiran P, Ziegler JB, Stewart GJ, et al. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 1993; 167(2): 441-4.
[http://dx.doi.org/10.1093/infdis/167.2.441] [PMID: 8421177]
[27]
Liang K, Gui X, Zhang YZ, Zhuang K, Meyers K, Ho DD. A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis 2009; 200(5): 682-6.
[http://dx.doi.org/10.1086/605123] [PMID: 19627245]
[28]
Humphrey JH, Marinda E, Mutasa K, et al. ZVITAMBO study group. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 2010; 341: c6580.
[http://dx.doi.org/10.1136/bmj.c6580] [PMID: 21177735]
[29]
Bain LE, Nkoke C, Noubiap JJN. UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades”. BMJ Glob Health 2017; 2(2): e000227.
[http://dx.doi.org/10.1136/bmjgh-2016-000227] [PMID: 28589026]
[30]
Cohen MS, Chen YQ, McCauley M, et al. HPTN 052 Study Team. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med 2016; 375(9): 830-9.
[http://dx.doi.org/10.1056/NEJMoa1600693] [PMID: 27424812]
[31]
Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou SS, Zhang XC, et al. Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial. Journal of acquired immune deficiency syndromes 2017; 74(1): 112-6.
[32]
Bhatt SJ, Douglas N. Undetectable equals untransmittable (U = U): implications for preconception counseling for human immunodeficiency virus serodiscordant couples. American journal of obstetrics and gynecology 2020; 222(1): 53.
[33]
Sullivan KM. Male self-disclosure of HIV-positive serostatus to sex partners: a review of the literature. J Assoc Nurses AIDS Care 2005; 16(6): 33-47.
[http://dx.doi.org/10.1016/j.jana.2005.09.005] [PMID: 16536263]
[34]
Kairania R, Gray RH, Kiwanuka N, et al. Disclosure of HIV results among discordant couples in Rakai, Uganda: a facilitated couple counselling approach. AIDS Care 2010; 22(9): 1041-51.
[http://dx.doi.org/10.1080/09540121003602226] [PMID: 20824557]
[35]
Allen S, Tice J, Van de Perre P, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 1992; 304(6842): 1605-9.
[http://dx.doi.org/10.1136/bmj.304.6842.1605] [PMID: 1628088]
[36]
Kinuthia J, Pintye J, Abuna F, Mugwanya KK, Lagat H, Onyango D, et al. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. Lancet HIV 2019.
[PMID: 31813837]